| Dr Ranella Hirsch, MD | |
|
777 Concord Ave Ste 206, Cambridge, MA 02138-1053 | |
| (617) 868-8685 | |
| Not Available |
| Full Name | Dr Ranella Hirsch |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 777 Concord Ave Ste 206, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528113883 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 216043 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ranella Hirsch, MD 777 Concord Ave Ste 206, Cambridge, MA 02138-1053 Ph: (617) 868-8685 | Dr Ranella Hirsch, MD 777 Concord Ave Ste 206, Cambridge, MA 02138-1053 Ph: (617) 868-8685 |
News Archive
When given a choice, older people prefer to read negative news, rather than positive news, about young adults, a new study suggests.
Despite the fact that bowel cancer is the third most common form of the disease in Britain and kills 16,000 people every year, the government watchdog on drugs the National Institute for Health and Clinical Excellence (NICE) has sparked a bitter controversy by refusing to provide two bowel cancer drugs on the National Health Service (NHS) to cancer patients.
Urodynamix Technologies Ltd. today reported its financial results for its fiscal third quarter ended September 30, 2009. The Company reported a loss of $638,287 or $0.01 per share basic and diluted compared to a loss of $737,341or $0.01, basic and diluted, for the comparative quarter of the prior year. Revenue for the quarter ended September 30, 2009 at $15,285, decreased 55% over the same quarter of the prior year.
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
Vaxin Inc., a clinical stage vaccine development company, today announced that it has been awarded a contract valued at up to $21.7 million by the Office of Biomedical Advanced Research and Development Authority (BARDA) for pre-clinical assessment, final manufacturing process development and the supply of clinical materials to support an IND filing and first-in-man dose ranging study of the company's proprietary anthrax vaccine, AdVAV.
› Verified 6 days ago
Dr. Qing Yu Weng, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-492-3250 | |
Babu Singh, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 | |
Dr. Shlomit Halachmi, M.D. PH.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 75 Mount Auburn St, 3w, Cambridge, MA 02138 Phone: 617-495-5182 Fax: 617-384-8144 | |
Dr. Kay Shou-mei Kane, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Concord Ave, Suite 4100, Cambridge, MA 02138 Phone: 617-864-8822 Fax: 617-547-5367 |